{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T02:17:05Z","timestamp":1783131425507,"version":"3.54.6"},"reference-count":140,"publisher":"Elsevier","isbn-type":[{"value":"9780443343858","type":"print"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.irn.2025.03.001","type":"book-chapter","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T11:23:47Z","timestamp":1745321027000},"page":"357-393","source":"Crossref","is-referenced-by-count":4,"title":["Psychedelics for the treatment of end-of-life distress in patients with a life-threatening disease"],"prefix":"10.1016","author":[{"given":"Stephan","family":"Tap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tijmen","family":"Bostoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"Breeksema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Schoevers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/bs.irn.2025.03.001_bib1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/0269881119897615","article-title":"Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer","volume":"34","author":"Agin-Liebes","year":"2020","journal-title":"Journal of Psychopharmacology"},{"issue":"7","key":"10.1016\/bs.irn.2025.03.001_bib2","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/cncr.35010","article-title":"Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder","volume":"130","author":"Agrawal","year":"2024","journal-title":"Cancer"},{"issue":"16_","key":"10.1016\/bs.irn.2025.03.001_bib3","article-title":"Long term efficacy of psilocybin in patients with cancer and major depressive disorder (MDD)","volume":"41","author":"Agrawal","year":"2023","journal-title":"Journal of Clinical Oncology"},{"issue":"11","key":"10.1016\/bs.irn.2025.03.001_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e21243","article-title":"Factors influencing cancer patients\u2019 caregivers\u2019 burden and quality of life: An integrative review","volume":"9","author":"Akter","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/bs.irn.2025.03.001_bib5","series-title":"Diagnostic and statistical manual of mental disorders - text revision (TR)","author":"American Psychiatric","year":"2022"},{"key":"10.1016\/bs.irn.2025.03.001_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100538","article-title":"Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study","volume":"27","author":"Anderson","year":"2020","journal-title":"eClinicalMedicine"},{"issue":"8","key":"10.1016\/bs.irn.2025.03.001_bib7","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2174\/1389450118666170317162603","article-title":"The use of methylphenidate for physical and psychological symptoms in cancer patients: A review","volume":"19","author":"Andrew","year":"2018","journal-title":"Current Drug Targets"},{"issue":"2","key":"10.1016\/bs.irn.2025.03.001_bib8","doi-asserted-by":"crossref","DOI":"10.1097\/WNF.0b013e318170576c","article-title":"Methylphenidate for the treatment of Parkinson disease and other neurological disorders","volume":"32","author":"Auriel","year":"2009","journal-title":"Clinical Neuropharmacology"},{"issue":"5","key":"10.1016\/bs.irn.2025.03.001_bib9","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1017\/S1478951519001020","article-title":"Comparing the physical, psychological, social, and spiritual needs of patients with non-cancer and cancer diagnoses in a tertiary palliative care setting","volume":"18","author":"Bandeali","year":"2020","journal-title":"Palliative and Supportive Care"},{"key":"10.1016\/bs.irn.2025.03.001_bib10","series-title":"Current topics in behavioral neurosciences","first-page":"393","article-title":"Classic hallucinogens and mystical experiences: Phenomenology and neural correlates","author":"Barrett","year":"2018"},{"key":"10.1016\/bs.irn.2025.03.001_bib11","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.2147\/NDT.S178263","article-title":"Neuropsychiatric disturbances in atypical parkinsonian disorders","volume":"14","author":"Belvisi","year":"2018","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"3","key":"10.1016\/bs.irn.2025.03.001_bib12","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jpainsymman.2010.05.010","article-title":"Existential suffering in the palliative care setting: An integrated literature review","volume":"41","author":"Boston","year":"2011","journal-title":"Journal of Pain and Symptom Management"},{"issue":"3","key":"10.1016\/bs.irn.2025.03.001_bib13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/pon.6095","article-title":"Relationship between demoralization and quality of life in end\u2010of\u2010life cancer patients","volume":"32","author":"Bovero","year":"2023","journal-title":"Psycho-Oncology"},{"issue":"3","key":"10.1016\/bs.irn.2025.03.001_bib14","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA: a Cancer Journal for Clinicians"},{"issue":"15","key":"10.1016\/bs.irn.2025.03.001_bib15","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1002\/cncr.31539","article-title":"Individual meaning\u2010centered psychotherapy for the treatment of psychological and existential distress: A randomized controlled trial in patients with advanced cancer","volume":"124","author":"Breitbart","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/bs.irn.2025.03.001_bib16","series-title":"Individual meaning-centered psychotherapy for patients with advanced cancer: A treatment manual","author":"Breitbart","year":"2014"},{"issue":"8","key":"10.1016\/bs.irn.2025.03.001_bib17","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1177\/0269216314526272","article-title":"The effects of advance care planning on end-of-life care: A systematic review","volume":"28","author":"Brinkman-Stoppelenburg","year":"2014","journal-title":"Palliative Medicine"},{"issue":"11","key":"10.1016\/bs.irn.2025.03.001_bib18","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1038\/npp.2017.84","article-title":"The Therapeutic potential of psychedelic drugs: Past, present, and future","volume":"42","author":"Carhart-Harris","year":"2017","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/bs.irn.2025.03.001_bib19","doi-asserted-by":"crossref","first-page":"E471","DOI":"10.1097\/NCC.0000000000000925","article-title":"Existential distress in cancer patients: A concept analysis","volume":"45","author":"Chen","year":"2022","journal-title":"Cancer Nursing"},{"key":"10.1016\/bs.irn.2025.03.001_bib20","series-title":"Dignity therapy: Final words for final days","author":"Chochinov","year":"2012"},{"issue":"11","key":"10.1016\/bs.irn.2025.03.001_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188141","article-title":"Correction: Dignity and distress towards the end of life across four non-cancer populations","volume":"12","author":"Chochinov","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/bs.irn.2025.03.001_bib22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jcbs.2019.11.004","article-title":"Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety","volume":"15","author":"Davis","year":"2020","journal-title":"Journal of Contextual Behavioral Science"},{"issue":"4","key":"10.1016\/bs.irn.2025.03.001_bib23","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41591-022-01744-z","article-title":"Increased global integration in the brain after psilocybin therapy for depression","volume":"28","author":"Daws","year":"2022","journal-title":"Nature Medicine"},{"issue":"4","key":"10.1016\/bs.irn.2025.03.001_bib33","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0010-440X(82)90085-2","article-title":"Subjective incompetence, the clinical hallmark of demoralization","volume":"23","author":"de Figueiredo","year":"1982","journal-title":"Comprehensive Psychiatry"},{"key":"10.1016\/bs.irn.2025.03.001_bib121","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.724606","article-title":"Psychedelics and neuroplasticity: A systematic review unraveling the biological underpinnings of psychedelics","volume":"12","author":"de Vos","year":"2021","journal-title":"Frontiers in Psychiatry"},{"issue":"5","key":"10.1016\/bs.irn.2025.03.001_bib24","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00520-008-0529-7","article-title":"Symptom distress in advanced cancer patients with anxiety and depression in the palliative care setting","volume":"17","author":"Delgado-Guay","year":"2009","journal-title":"Supportive Care in Cancer"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.001_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40263-012-0017-y","article-title":"Methylphenidate","volume":"27","author":"Devos","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/bs.irn.2025.03.001_bib26","unstructured":"EMA. (2024). EMA multi-stakeholder workshop on psychedelics. https:\/\/www.ema.europa.eu\/en\/documents\/report\/report-ema-multi-stakeholder-workshop-psychedelics_en.pdf."},{"issue":"6","key":"10.1016\/bs.irn.2025.03.001_bib27","doi-asserted-by":"crossref","DOI":"10.7326\/0003-4819-132-6-200003210-00005","article-title":"Understanding economic and other burdens of terminal illness: The experience of patients and their caregivers","volume":"132","author":"Emanuel","year":"2000","journal-title":"Annals of Internal Medicine"},{"issue":"6","key":"10.1016\/bs.irn.2025.03.001_bib28","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1177\/003591576706000618","article-title":"A psychological setting of somatic disease: The \u2018Giving up \u2014 Given Up\u2019 complex","volume":"60","author":"Engel","year":"1967","journal-title":"Proceedings of the Royal Society of Medicine"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.001_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000288931","article-title":"Diagnostic criteria for use in psychosomatic research","volume":"63","author":"Fava","year":"1995","journal-title":"Psychotherapy and Psychosomatics"},{"issue":"3","key":"10.1016\/bs.irn.2025.03.001_bib30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000530760","article-title":"Clinical characterization of demoralization","volume":"92","author":"Fava","year":"2023","journal-title":"Psychotherapy and Psychosomatics"},{"key":"10.1016\/bs.irn.2025.03.001_bib31","unstructured":"FDA. (2023). Psychedelic drugs: Considerations for clinical investigations. C. f. D. E. a. Research. https:\/\/www.fda.gov\/media\/169694\/download."},{"key":"10.1016\/bs.irn.2025.03.001_bib32","unstructured":"FDA. (2024). Psychedelic drugs in psychiatry: An American regulatory\/FDA perspective. https:\/\/www.ema.europa.eu\/en\/documents\/presentation\/presentation-american-regulatory-perspective-psychedelic-drugs-psychiatry-m-sokolowska_en.pdf."},{"issue":"4","key":"10.1016\/bs.irn.2025.03.001_bib34","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/09540261.2018.1481827","article-title":"Psychedelics as anti-inflammatory agents","volume":"30","author":"Flanagan","year":"2018","journal-title":"International Review of Psychiatry"},{"key":"10.1016\/bs.irn.2025.03.001_bib35","series-title":"Persuasion and healing","author":"Frank","year":"1973"},{"key":"10.1016\/bs.irn.2025.03.001_bib36","series-title":"Man\u2019s search for meaning","author":"Frankl","year":"1959"},{"issue":"3","key":"10.1016\/bs.irn.2025.03.001_bib37","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1037\/h0087982","article-title":"Logotherapy and existentialism","volume":"4","author":"Frankl","year":"1967","journal-title":"Psychotherapy: Theory, Research & Practice"},{"issue":"7","key":"10.1016\/bs.irn.2025.03.001_bib38","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1089\/jpm.2017.0576","article-title":"Psychotherapy targeting depression and anxiety for use in palliative care: A meta-analysis","volume":"21","author":"Fulton","year":"2018","journal-title":"Journal of Palliative Medicine"},{"issue":"9","key":"10.1016\/bs.irn.2025.03.001_bib39","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1177\/00048674211060746","article-title":"Mental state of demoralisation across diverse clinical settings: A systematic review, meta-analysis and proposal for its use as a \u2018specifier\u2019 in mental illness","volume":"56","author":"Gan","year":"2021","journal-title":"Australian & New Zealand Journal of Psychiatry"},{"issue":"4","key":"10.1016\/bs.irn.2025.03.001_bib40","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/09699260.2024.2374602","article-title":"Contributions of the compassionate care approach to psychedelic-assisted therapies in hospice and palliative care","volume":"32","author":"Garcia","year":"2024","journal-title":"Progress in Palliative Care"},{"issue":"5","key":"10.1016\/bs.irn.2025.03.001_bib41","doi-asserted-by":"crossref","DOI":"10.1007\/s00520-023-07722-6","article-title":"Demoralization and spirituality in oncology: An integrative systematic review","volume":"31","author":"Garcia","year":"2023","journal-title":"Supportive Care in Cancer"},{"issue":"7","key":"10.1016\/bs.irn.2025.03.001_bib42","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/NMD.0000000000000113","article-title":"Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases","volume":"202","author":"Gasser","year":"2014","journal-title":"The Journal of Nervous and Mental Disease"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.001_bib43","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/0269881114555249","article-title":"LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects","volume":"29","author":"Gasser","year":"2015","journal-title":"Journal of Psychopharmacology"},{"issue":"2","key":"10.1016\/bs.irn.2025.03.001_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/medsci7020025","article-title":"Spiritual care in Palliative care: A systematic review of the recent European literature","volume":"7","author":"Gijsberts","year":"2019","journal-title":"Medical Sciences"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.001_bib45","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/09540261.2013.842542","article-title":"Efficacy and safety of pharmacotherapy in cancer-related psychiatric disorders across the trajectory of cancer care: A review","volume":"26","author":"Grassi","year":"2014","journal-title":"International Review of Psychiatry"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.001_bib46","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/annonc\/mdx526","article-title":"The use of antidepressants in oncology: A review and practical tips for oncologists","volume":"29","author":"Grassi","year":"2018","journal-title":"Annals of Oncology"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.001_bib47","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/jpm.2016.0422","article-title":"Existential suffering part 1: Definition and diagnosis #319","volume":"20","author":"Grech","year":"2016","journal-title":"Journal of Palliative Medicine"},{"issue":"12","key":"10.1016\/bs.irn.2025.03.001_bib48","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"Journal of Psychopharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.001_bib49","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archgenpsychiatry.2010.116","article-title":"Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer","volume":"68","author":"Grob","year":"2011","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1016\/bs.irn.2025.03.001_bib50","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000467984","article-title":"LSD-assisted psychotherapy in patients with terminal cancer","volume":"8","author":"Grof","year":"1973","journal-title":"International Pharmacopsychiatry"},{"issue":"2","key":"10.1016\/bs.irn.2025.03.001_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph20021570","article-title":"Quality of life in caregivers of cancer patients: A literature review","volume":"20","author":"Guerra-Mart\u00edn","year":"2023","journal-title":"International Journal of Environmental Research and Public Health"},{"key":"10.1016\/bs.irn.2025.03.001_bib52","first-page":"1","article-title":"The psychedelic renaissance in clinical research: A bibliometric analysis of three decades of human studies with classical psychedelics","author":"Hadar","year":"2022","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1016\/bs.irn.2025.03.001_bib53","first-page":"1","article-title":"Scoping review of experiential measures from psychedelic research and clinical trials","author":"Herrmann","year":"2022","journal-title":"Journal of Psychoactive Drugs"},{"issue":"5","key":"10.1016\/bs.irn.2025.03.001_bib54","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10608-012-9476-1","article-title":"The efficacy of cognitive behavioral therapy: A review of meta-analyses","volume":"36","author":"Hofmann","year":"2012","journal-title":"Cognitive Therapy and Research"},{"issue":"3","key":"10.1016\/bs.irn.2025.03.001_bib55","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.biopsych.2022.08.025","article-title":"Lysergic acid diethylamide\u2013assisted therapy in patients with anxiety with and without a life-threatening illness: A randomized, double-blind, placebo-controlled phase ii study","volume":"93","author":"Holze","year":"2023","journal-title":"Biological Psychiatry"},{"key":"10.1016\/bs.irn.2025.03.001_bib56","first-page":"1","article-title":"LSD-assisted therapy in patients with anxiety: Open-label prospective 12-month follow-up","author":"Holze","year":"2024","journal-title":"The British Journal of Psychiatry"},{"issue":"7","key":"10.1016\/bs.irn.2025.03.001_bib57","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jamda.2014.01.008","article-title":"Efficacy of advance care planning: A systematic review and meta-analysis","volume":"15","author":"Houben","year":"2014","journal-title":"Journal of the American Medical Directors Association"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.001_bib58","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/02698811231200019","article-title":"Assessment of the acute subjective psychedelic experience: A review of patient-reported outcome measures in clinical research on classical psychedelics","volume":"38","author":"Hovmand","year":"2023","journal-title":"Journal of Psychopharmacology"},{"issue":"2","key":"10.1016\/bs.irn.2025.03.001_bib59","doi-asserted-by":"crossref","first-page":"E487","DOI":"10.1097\/NCC.0000000000000940","article-title":"Psychological distress among patients with advanced cancer: A conceptual analysis","volume":"45","author":"Huda","year":"2022","journal-title":"Cancer Nursing"},{"key":"10.1016\/bs.irn.2025.03.001_bib60","series-title":"This timeless moment","author":"Huxley","year":"1968"},{"key":"10.1016\/bs.irn.2025.03.001_bib61","first-page":"1","article-title":"Spiritual care interventions for palliative care patients: A scoping review","author":"Jaman-Mewes","year":"2024","journal-title":"Palliative and Supportive Care"},{"issue":"6","key":"10.1016\/bs.irn.2025.03.001_bib62","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/0269881108093587","article-title":"Human hallucinogen research: Guidelines for safety","volume":"22","author":"Johnson","year":"2008","journal-title":"Journal of Psychopharmacology"},{"issue":"2","key":"10.1016\/bs.irn.2025.03.001_bib63","first-page":"80","article-title":"LSD and the dying patient","volume":"26","author":"Kast","year":"1966","journal-title":"The Chicago Medical School Quarterly"},{"issue":"4","key":"10.1016\/bs.irn.2025.03.001_bib64","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/BF01575629","article-title":"Attenuation of anticipation: A therapeutic use of lysergic acid diethylamide","volume":"41","author":"Kast","year":"1967","journal-title":"The Psychiatric Quarterly"},{"key":"10.1016\/bs.irn.2025.03.001_bib65","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1213\/00000539-196405000-00013","article-title":"Study of Lysergic acid diethylamide as an analgesic agent","volume":"43","author":"Kast","year":"1964","journal-title":"Anesthesia & Analgesia"},{"issue":"19","key":"10.1016\/bs.irn.2025.03.001_bib66","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1001\/archinternmed.2012.3633","article-title":"The relief of existential suffering","volume":"172","author":"Kissane","year":"2012","journal-title":"Archives of Internal Medicine"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.001_bib67","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/082585970101700103","article-title":"Demoralization syndrome \u2014 A relevant psychiatric diagnosis for Palliative care","volume":"17","author":"Kissane","year":"2001","journal-title":"Journal of Palliative Care"},{"key":"10.1016\/bs.irn.2025.03.001_bib68","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/9781119784395.ch10","article-title":"Pain and its management","author":"Kitchen","year":"2024","journal-title":"Handbook of Palliative Care"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.001_bib69","doi-asserted-by":"crossref","DOI":"10.1002\/pon.6281","article-title":"Managing cancer and living meaningfully (CALM): Implementation in Dutch cancer care","volume":"33","author":"Kool","year":"2024","journal-title":"Psycho-Oncology"},{"issue":"2","key":"10.1016\/bs.irn.2025.03.001_bib70","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/pon.3409","article-title":"Prevalence of depression in cancer patients: A meta\u2010analysis of diagnostic interviews and self\u2010report instruments","volume":"23","author":"Krebber","year":"2014","journal-title":"Psycho-Oncology"},{"issue":"1-2","key":"10.1016\/bs.irn.2025.03.001_bib71","first-page":"644","article-title":"Psychedelic drug assisted psychotherapy in patients with terminal cancer","volume":"2","author":"Kurland","year":"1972","journal-title":"Journal of Thanatology"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.001_bib72","doi-asserted-by":"crossref","DOI":"10.1186\/s12904-019-0417-6","article-title":"How to come to terms with facing death: A qualitative study examining the experiences of patients with terminal cancer","volume":"18","author":"Kyota","year":"2019","journal-title":"BMC Palliative Care"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.001_bib73","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1471-244X-13-140","article-title":"Antidepressants in the treatment of depression\/depressive symptoms in cancer patients: A systematic review and meta-analysis","volume":"13","author":"Laoutidis","year":"2013","journal-title":"BMC Psychiatry"},{"issue":"3","key":"10.1016\/bs.irn.2025.03.001_bib74","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.cpr.2007.07.013","article-title":"Treatment of existential distress in life threatening illness: A review of manualized interventions\u204e","volume":"28","author":"Lemay","year":"2008","journal-title":"Clinical Psychology Review"},{"key":"10.1016\/bs.irn.2025.03.001_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.1030630","article-title":"The efficacy of cognitive behavioral therapy for cancer: A scientometric analysis [original research]","volume":"13","author":"Lin","year":"2022","journal-title":"Frontiers in Psychiatry"},{"issue":"2-3","key":"10.1016\/bs.irn.2025.03.001_bib76","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jad.2012.03.025","article-title":"Anxiety and depression after cancer diagnosis: Prevalence rates by cancer type, gender, and age","volume":"141","author":"Linden","year":"2012","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/bs.irn.2025.03.001_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1180317","article-title":"Factors related to the quality of life of family cancer caregivers [original research]","volume":"14","author":"Liu","year":"2023","journal-title":"Frontiers in Psychiatry"},{"issue":"6","key":"10.1016\/bs.irn.2025.03.001_bib78","doi-asserted-by":"crossref","DOI":"10.1111\/ecc.12597","article-title":"Preliminary psychometrics of the existential distress scale in patients with advanced cancer","volume":"26","author":"Lo","year":"2017","journal-title":"European Journal of Cancer Care"},{"issue":"9","key":"10.1016\/bs.irn.2025.03.001_bib79","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2016.0483","article-title":"Clinical diagnosis of mental disorders immediately before and after cancer diagnosis","volume":"2","author":"Lu","year":"2016","journal-title":"JAMA Oncology"},{"issue":"10","key":"10.1016\/bs.irn.2025.03.001_bib80","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1177\/02698811241269751","article-title":"Psilocybin for clinical indications: A scoping review","volume":"38","author":"Madden","year":"2024","journal-title":"Journal of Psychopharmacology"},{"issue":"3","key":"10.1016\/bs.irn.2025.03.001_bib81","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1080\/02791072.2020.1854399","article-title":"The ritual use of ayahuasca during treatment of severe physical illnesses: A qualitative study","volume":"53","author":"Maia","year":"2021","journal-title":"Journal of Psychoactive Drugs"},{"issue":"6","key":"10.1016\/bs.irn.2025.03.001_bib82","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1177\/0269216316665562","article-title":"Dignity therapy\u2019, a promising intervention in palliative care: A comprehensive systematic literature review","volume":"31","author":"Mart\u00ednez","year":"2017","journal-title":"Palliative Medicine"},{"issue":"5","key":"10.1016\/bs.irn.2025.03.001_bib83","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s11096-015-0094-3","article-title":"Medication use during end-of-life care in a Palliative care centre","volume":"37","author":"Masman","year":"2015","journal-title":"International Journal of Clinical Pharmacy"},{"issue":"10","key":"10.1016\/bs.irn.2025.03.001_bib84","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1007\/s00520-019-04907-w","article-title":"Psychostimulants for cancer-related cognitive impairment in adult cancer survivors: A systematic review and meta-analysis","volume":"27","author":"Miladi","year":"2019","journal-title":"Supportive Care in Cancer"},{"issue":"8","key":"10.1016\/bs.irn.2025.03.001_bib85","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1002\/cncr.22980","article-title":"Psychiatric disorders in advanced cancer","volume":"110","author":"Miovic","year":"2007","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/bs.irn.2025.03.001_bib86","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1470-2045(11)70002-X","article-title":"Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: A meta-analysis of 94 interview-based studies","volume":"12","author":"Mitchell","year":"2011","journal-title":"The Lancet Oncology"},{"issue":"4","key":"10.1016\/bs.irn.2025.03.001_bib87","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jpainsymman.2013.11.009","article-title":"Are there differences in the prevalence of Palliative care-related problems in people living with advanced cancer and eight non-cancer conditions? A systematic review","volume":"48","author":"Moens","year":"2014","journal-title":"Journal of Pain and Symptom Management"},{"issue":"9","key":"10.1016\/bs.irn.2025.03.001_bib88","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1080\/17512433.2021.1933434","article-title":"Blinding and expectancy confounds in psychedelic randomized controlled trials","volume":"14","author":"Muthukumaraswamy","year":"2021","journal-title":"Expert Review of Clinical Pharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.001_bib89","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"1-3","key":"10.1016\/bs.irn.2025.03.001_bib90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2010.07.034","article-title":"The prevalence and pharmacotherapy of depression in cancer patients","volume":"131","author":"Ng","year":"2011","journal-title":"Journal of Affective Disorders"},{"issue":"2","key":"10.1016\/bs.irn.2025.03.001_bib91","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacological Reviews"},{"issue":"5","key":"10.1016\/bs.irn.2025.03.001_bib92","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1177\/0269216311425096","article-title":"Managing cancer and living meaningfully (CALM): A qualitative study of a brief individual psychotherapy for individuals with advanced cancer","volume":"26","author":"Nissim","year":"2012","journal-title":"Palliative Medicine"},{"key":"10.1016\/bs.irn.2025.03.001_bib93","article-title":"The subjective effects of psychedelics may not be necessary for their enduring therapeutic effects","volume":"2021","author":"Olson","year":"2020","journal-title":"ACS Pharmacology & Translational Science"},{"issue":"4","key":"10.1016\/bs.irn.2025.03.001_bib94","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011006.pub3","article-title":"Antidepressants for the treatment of depression in people with cancer","author":"Ostuzzi","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/bs.irn.2025.03.001_bib95","first-page":"144","article-title":"LSD-assisted psychotherapy with terminal cancer patients","volume":"9","author":"Pahnke","year":"1969","journal-title":"Current Psychiatric Therapies"},{"issue":"2","key":"10.1016\/bs.irn.2025.03.001_bib96","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/08919887221103575","article-title":"Prevalence and correlates of psychiatric comorbidity and multimorbidity in Parkinson\u2019s disease and atypical Parkinsonian syndromes","volume":"36","author":"Patel","year":"2023","journal-title":"Journal of Geriatric Psychiatry and Neurology"},{"issue":"11","key":"10.1016\/bs.irn.2025.03.001_bib97","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1017\/S0033291709992285","article-title":"Depression and cancer mortality: A meta-analysis","volume":"40","author":"Pinquart","year":"2010","journal-title":"Psychological Medicine"},{"key":"10.1016\/bs.irn.2025.03.001_bib98","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.k1415","article-title":"Depression and anxiety in patients with cancer","author":"Pitman","year":"2018","journal-title":"BMJ (Clinical Research ed.)"},{"key":"10.1016\/bs.irn.2025.03.001_bib99","doi-asserted-by":"crossref","DOI":"10.1177\/2632352419895527","article-title":"Midazolam: An essential palliative care drug","volume":"14","author":"Prommer","year":"2020","journal-title":"Palliative Care and Social Practice"},{"issue":"2","key":"10.1016\/bs.irn.2025.03.001_bib100","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1556\/2054.2022.00218","article-title":"Psychedelics and mindfulness: A systematic review and meta-analysis","volume":"6","author":"Radakovic","year":"2022","journal-title":"Journal of Psychedelic Studies"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.001_bib101","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/0269216310380764","article-title":"Antidepressants for the treatment of depression in palliative care: Systematic review and meta-analysis","volume":"25","author":"Rayner","year":"2010","journal-title":"Palliative Medicine"},{"issue":"3","key":"10.1016\/bs.irn.2025.03.001_bib102","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2174\/1574886313666180605095130","article-title":"Adverse effects of antidepressants reported by a large international Cohort: Emotional blunting, suicidality, and withdrawal effects","volume":"13","author":"Read","year":"2018","journal-title":"Current Drug Safety"},{"issue":"2","key":"10.1016\/bs.irn.2025.03.001_bib103","first-page":"121","article-title":"LSD-assisted psychotherapy and the human encounter with death","volume":"4","author":"Richards","year":"1972","journal-title":"Journal of Transpersonal Psychology"},{"issue":"9","key":"10.1016\/bs.irn.2025.03.001_bib104","doi-asserted-by":"crossref","first-page":"e543","DOI":"10.1016\/S1470-2045(17)30582-X","article-title":"Definition and recommendations for advance care planning: An international consensus supported by the European Association for Palliative care","volume":"18","author":"Rietjens","year":"2017","journal-title":"The Lancet Oncology"},{"issue":"3","key":"10.1016\/bs.irn.2025.03.001_bib105","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jpainsymman.2014.07.008","article-title":"A systematic review of the demoralization syndrome in individuals with progressive disease and cancer: A decade of research","volume":"49","author":"Robinson","year":"2015","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1016\/bs.irn.2025.03.001_bib106","series-title":"Managing cancer and living meaningfully: An evidence-based intervention for cancer patients and their caregivers","author":"Rodin","year":"2021"},{"issue":"23","key":"10.1016\/bs.irn.2025.03.001_bib107","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1200\/JCO.2017.77.1097","article-title":"Managing cancer and living meaningfully (CALM): A randomized controlled trial of a psychological intervention for patients with advanced cancer","volume":"36","author":"Rodin","year":"2018","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10.1016\/bs.irn.2025.03.001_bib108","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/pon.4578","article-title":"Why Is meaning-centered group psychotherapy (MCGP) effective? Enhanced sense of meaning as the mechanism of change for advanced cancer patients","volume":"27","author":"Rosenfeld","year":"2018","journal-title":"Psycho-Oncology"},{"issue":"12","key":"10.1016\/bs.irn.2025.03.001_bib109","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/0269881116675512","article-title":"Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: A randomized controlled trial","volume":"30","author":"Ross","year":"2016","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/bs.irn.2025.03.001_bib110","doi-asserted-by":"crossref","unstructured":"Rozans, M., Dreisbach, A., Lertora, J. J. L., & Kahn, M. J. Palliative uses of methylphenidate in patients with cancer: A review. Journal of Clinical Oncology, 20(1), 335\u2013339. https:\/\/doi.org\/10.1200\/JCO.2002.20.1.335.","DOI":"10.1200\/JCO.2002.20.1.335"},{"issue":"22","key":"10.1016\/bs.irn.2025.03.001_bib111","doi-asserted-by":"crossref","first-page":"5349","DOI":"10.1002\/cncr.24561","article-title":"Depression as a predictor of disease progression and mortality in cancer patients","volume":"115","author":"Satin","year":"2009","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.001_bib112","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00213-021-06027-y","article-title":"Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: A systematic review","volume":"239","author":"Schimmers","year":"2022","journal-title":"Psychopharmacology"},{"issue":"9","key":"10.1016\/bs.irn.2025.03.001_bib113","article-title":"Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases","volume":"2024","author":"Schipper","year":"2024","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/bs.irn.2025.03.001_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpr.2023.102353","article-title":"Cognitive behavioral therapies for depression and anxiety in people with chronic disease: A systematic review and meta-analysis","volume":"106","author":"Scott","year":"2023","journal-title":"Clinical Psychology Review"},{"key":"10.1016\/bs.irn.2025.03.001_bib115","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jad.2022.11.046","article-title":"Psilocybin-assisted therapy improves psycho-social-spiritual well-being in cancer patients","volume":"323","author":"Shnayder","year":"2023","journal-title":"Journal of Affective Disorders"},{"issue":"7","key":"10.1016\/bs.irn.2025.03.001_bib116","doi-asserted-by":"crossref","first-page":"e883","DOI":"10.1016\/S2214-109X(19)30172-X","article-title":"The escalating global burden of serious health-related suffering: Projections to 2060 by world regions, age groups, and health conditions","volume":"7","author":"Sleeman","year":"2019","journal-title":"The Lancet Global Health"},{"key":"10.1016\/bs.irn.2025.03.001_bib117","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jcbs.2019.11.002","article-title":"Psilocybin-assisted therapy of major depressive disorder using acceptance and commitment therapy as a therapeutic frame","volume":"15","author":"Sloshower","year":"2020","journal-title":"Journal of Contextual Behavioral Science"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.001_bib118","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-58318-x","article-title":"Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: Results from an exploratory placebo-controlled trial","volume":"14","author":"Sloshower","year":"2024","journal-title":"Scientific Reports"},{"issue":"8","key":"10.1016\/bs.irn.2025.03.001_bib119","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1017\/S0033291723003653","article-title":"Assessing expectancy and suggestibility in a trial of escitalopram v. Psilocybin for depression","volume":"54","author":"Szigeti","year":"2024","journal-title":"Psychological Medicine"},{"issue":"3","key":"10.1016\/bs.irn.2025.03.001_bib120","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s10591-012-9201-y","article-title":"A literature review of therapeutic expectancy effects","volume":"34","author":"Tambling","year":"2012","journal-title":"Contemporary Family Therapy"},{"issue":"3","key":"10.1016\/bs.irn.2025.03.001_bib122","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/00006842-199705000-00011","article-title":"Psychological sequelae of cancer diagnosis","volume":"59","author":"van\u2019t Spijker","year":"1997","journal-title":"Psychosomatic Medicine"},{"issue":"6","key":"10.1016\/bs.irn.2025.03.001_bib123","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.jpainsymman.2015.12.340","article-title":"Update on prevalence of pain in patients with cancer: Systematic review and meta-analysis","volume":"51","author":"van den Beuken-van Everdingen","year":"2016","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1016\/bs.irn.2025.03.001_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104793","article-title":"Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review","volume":"140","author":"van Elk","year":"2022","journal-title":"Neuroscience & Biobehavioral Reviews"},{"issue":"11","key":"10.1016\/bs.irn.2025.03.001_bib125","first-page":"2525","article-title":"Existential distress in cancer","volume":"27","author":"Vehling","year":"2018","journal-title":"Alleviating suffering from fundamental loss and change. Psycho-Oncology"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.001_bib126","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/SPC.0000000000000324","article-title":"Existential distress and meaning-focused interventions in cancer survivorship","volume":"12","author":"Vehling","year":"2018","journal-title":"Current Opinion in Supportive & Palliative Care"},{"issue":"167","key":"10.1016\/bs.irn.2025.03.001_bib127","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0170-2022","article-title":"Nonpharmacological management of psychological distress in people with COPD","volume":"32","author":"Volpato","year":"2023","journal-title":"European Respiratory Review"},{"issue":"5","key":"10.1016\/bs.irn.2025.03.001_bib128","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/YCO.0000000000000441","article-title":"Psychological interventions in palliative care","volume":"31","author":"von Blanckenburg","year":"2018","journal-title":"Current Opinion in Psychiatry"},{"issue":"10","key":"10.1016\/bs.irn.2025.03.001_bib129","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1177\/0269216317705101","article-title":"The effects of life review interventions on spiritual well-being, psychological distress, and quality of life in patients with terminal or advanced cancer: A systematic review and meta-analysis of randomized controlled trials","volume":"31","author":"Wang","year":"2017","journal-title":"Palliative Medicine"},{"issue":"11","key":"10.1016\/bs.irn.2025.03.001_bib130","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1177\/10499091231154887","article-title":"Prevalence, associated factors and adverse outcomes of demoralization in cancer patients: A decade of systematic review","volume":"40","author":"Wang","year":"2023","journal-title":"American Journal of Hospice and Palliative Medicine\u00ae"},{"key":"10.1016\/bs.irn.2025.03.001_bib131","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jcbs.2019.12.004","article-title":"The use of the psychological flexibility model to support psychedelic assisted therapy","volume":"15","author":"Watts","year":"2020","journal-title":"Journal of Contextual Behavioral Science"},{"key":"10.1016\/bs.irn.2025.03.001_bib132","unstructured":"WHO. (2020). Palliative care. World Health Organization. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/palliative-care."},{"key":"10.1016\/bs.irn.2025.03.001_bib133","unstructured":"WHO. (2022). Cancer. World Health Organization. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cancer."},{"key":"10.1016\/bs.irn.2025.03.001_bib134","article-title":"Opioids for cancer pain \u2010 an overview of Cochrane reviews","volume":"7","author":"Wiffen","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/bs.irn.2025.03.001_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpr.2022.102227","article-title":"Clinical utility of demoralization: A systematic review of the literature","volume":"99","author":"Wo\u017aniewicz","year":"2023","journal-title":"Clinical Psychology Review"},{"issue":"35","key":"10.1016\/bs.irn.2025.03.001_bib136","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000011948","article-title":"Are spiritual interventions beneficial to patients with cancer?","volume":"97","author":"Xing","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/bs.irn.2025.03.001_bib137","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1021\/acsptsci.0c00194","article-title":"The subjective effects of psychedelics are necessary for their enduring therapeutic effects","volume":"4","author":"Yaden","year":"2021","journal-title":"ACS Pharmacology and Translational Science"},{"key":"10.1016\/bs.irn.2025.03.001_bib138","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2024.1386321","article-title":"Alterations in brain network connectivity and subjective experience induced by psychedelics: A scoping review","volume":"15","author":"Yu","year":"2024","journal-title":"Frontiers in Psychiatry"},{"key":"10.1016\/bs.irn.2025.03.001_bib139","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108838","article-title":"Midazolam: Safety of use in palliative care: A systematic critical review","volume":"114","author":"Zaporowska-Stachowiak","year":"2019","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"6","key":"10.1016\/bs.irn.2025.03.001_bib140","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1159\/000514270","article-title":"Demoralization and quality of life of patients with Parkinson disease","volume":"90","author":"Zhu","year":"2021","journal-title":"Psychotherapy and Psychosomatics"}],"container-title":["International Review of Neurobiology","Psychedelics in Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774225000066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774225000066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T22:52:49Z","timestamp":1750287169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774225000066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9780443343858"],"references-count":140,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2025.03.001","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}